These are Singapore companies which may be in focus on Tuesday, 6 September 2021: Hongkong Land, Starhill Global REIT, NutryFarm International, AEM Holdings, Tianjin Zhongxin Pharmaceutical, AEI Corp., Ntegrator International and Hafary Holdings.
This item was originally published on Tuesday, 7 September 2021 at 12:57 a.m. SGT; it has since been updated to include Healthway Medical Corp.
Hongkong Land plans to allocate up to US$500 million in a share buyback program which will run through end-2022, the property investor and developer said in a filing to SGX Monday.
Starhill Global REIT
Starhill Global REIT has priced S$125 million 2.23 percent notes due 2028, as the series 003 notes to be issued under its S$2 billion multicurrency debt issuance program, the REIT’s manager said in a filing to SGX Monday.
NutryFarm International has landed a sales order of around 130 million yuan from Anhui Tianhe YouXuan Import for 200 containers of fresh Thailand durians, the fruit trader said in a filing to SGX Monday.
Abrdn PLC, the parent company of Aberdeen Asset Management, ceased to be a substantial shareholder of AEM Holdings, with its deemed interest falling to 4.816 percent from 5.273 percent after the issuance of 26.8 million new shares in the company to Temasek Holdings’ subsidiary Venezio Investments, according to a filing to SGX Monday.
Healthway Medical Corp. said Tuesday it will begin to offer the Sinopharm Covid-19 vaccine at selected general practitioner clinics in Singapore on Wednesday.
Via a sponsorship with property developer OUE, 1,000 doses will be made available for free for those aged 60 or above, the company said in a filing to SGX. The two-dose vaccine will be priced at S$99, the filing said.
The Sinopharm vaccine has met with strong demand when offered at other clinics in Singapore, according to media reports.
Tianjin Zhongxin Pharmaceutical
Tianjin Zhongxin Pharmaceutical said Monday it would appoint Guo Min, age 50, as chairman of the board and executive director.
Guo Min has been chairman of the board of directors and legal representative of Tianjin Pharmaceutical Holdings, which is the controlling shareholder, since 26 March, the company said in a filing to SGX. In addition, he has been a director of Shenzhen Angel Drinking Industry since 2005, and since 2020, he’s been a director of Jinhushen Biological Medical Science and Technology, the filing said.
MTBL Global Fund, formerly known as New Impetus Strategy Fund, acquired 462,500 shares of AEI Corp. for S$370,000 in an off-market transaction with a third party, bringing its direct interest to 39.58 percent, up from 39.05 percent previously, according to a filing to SGX Monday.
Sun Quan, who is executive director and controlling shareholder of AEI and holds the controlling interest in the fund manager of MTBL Global Fund, saw his deemed interest in AEI rise to 54.37 percent from 53.84 percent due to the deal, according to a separate filing to SGX.
Christian Kwok-Leun Yau Heilesen, CEO and executive director of Ntegrator International, boosted his deemed interest in the company to 13.67 percent from 13.66 percent previously after Mission Well Ltd., of which Heilesen is the sole shareholder, acquired 156,200 shares in the market for S$1,874, according to a filing to SGX.
Low Kok Ann, CEO and executive director of Hafary Holdings, acquired 135,000 shares in the company for S$22,275 in a market transaction, bringing his direct interest to 8.49 percent from 8.46 percent previously, according to a filing to SGX Monday.